Patents Assigned to GBF Gesellschaft fur Biotechnologische Forschung
  • Publication number: 20080120733
    Abstract: The invention relates to a method for the production of a eukaryotic cell selectable by inactivation or reduction of an endogenous gene function, comprising the steps of (a) introduction of one or more vectors into the cell and (b) expression of a siRNA and preferably shRNA coded by the one or more vectors, directed against an endogenous selectable gene and inactivating same, said siRNA or shRNA being the transcription product of an RNAi selection cassette, the selection cassette comprising a section of at least 19 nucleotides of the transcribed region of the gene, said selection being operatively linked to a promoter and a transcription termination signal.
    Type: Application
    Filed: June 16, 2005
    Publication date: May 22, 2008
    Applicant: GBF-GESELLSCHAFT FUR BIOTECHNOLOGISCHE FORSCHUNG
    Inventors: Martin Hafner, Karina Nawrath, Werner Muller
  • Patent number: 7316996
    Abstract: The invention provides lipopeptide conjugates in which a cysteine that is double-substituted by a fatty acid is bonded by means of the carboxyl group to a highly soluble, physiologically compatible and non-immunogenic, polymeric conjugate group. The conjugates exhibit an excellent macrophage stimulant action and do not require addition solutizing. They can be used in a wide range of applications, in particular for stimulating macrophages, for stimulating antibody synthesis, for combating infection, as an immunostimulant, in particular in relation to tumors, for preventing and treating septicaemic shock, for would healing and as an adjuvant for vaccines.
    Type: Grant
    Filed: July 18, 2003
    Date of Patent: January 8, 2008
    Assignee: GBF Gesellschaft fur Biotechnologische Forschung mbH
    Inventors: Peter Muhlradt, Michael Morr
  • Patent number: 5266608
    Abstract: Novel non-elastomeric biomedical adhesive compositions for calcified tissues, are described. The compositions are characterized by a network structure which is obtained by the reaction of a polyisocyanate having at least two isocyanate groups with at least one polyol which possesses surface wetting properties with the participation of compounds selected from calcium and phosphorus, optional in the presence of a catalyst. The polyisocyanate is selected from aliphatic, alicyclic and aromatic compounds and preferred amounts are in the range of 20% to 80% by weight of the total amount of reactants. The polyol is selected from polyalkylene ether glycols and polyester glycols containing between 25 to 75 carbon atoms and preferred amounts are in the range of 10% to 80% by weight of the total amount of reactants. The adhesive compositions were found to produce a fast bonding of the calcified tissues, with a joint strength of above 0.5 N/sq.mm.
    Type: Grant
    Filed: June 27, 1991
    Date of Patent: November 30, 1993
    Assignees: Technion Research & Dev't Foundation, Ltd., GBF Gesellschaft fur Biotechnologische Forschung
    Inventors: Dov Katz, Esther Brandeis, Joachim Klein